HOSPITAL & HEALTH FACILITIES TRUST
24F-2NT, 1997-02-26
Previous: HOSPITAL & HEALTH FACILITIES TRUST, NSAR-B, 1997-02-26
Next: CENTRAL EQUITY TRUST UTILITY SERIES 16, 24F-2NT, 1997-02-26



<PAGE>   1

                    U.S. SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                                   FORM 24F-2
                        ANNUAL NOTICE OF SECURITIES SOLD
                             PURSUANT TO RULE 24F-2


1.       Name and address of issuer:  Hospital and Health Facilities Trust


2.       Name of each series or class of funds for which this notice is filed:
         California Hospital and Health Facilities Liquid Asset Fund


3.       Investment Company Act File Number:  811-6575

         Securities Act File Number:  33-46137


4.       Last day of fiscal year for which this notice is filed:  December 31,
         1996


5.       Check box if this notice is being filed more than 180 days after the
         close of the issuer's fiscal year for purposes of reporting securities
         sold after the close of the fiscal year but before termination of the
         issuer's 24f-2 declaration:    [  ]


6.       Date of termination of issuer's declaration under rule 24f-2(a)(1), if
         applicable (see Instruction A.6):


7.       Number and amount of securities of the same class or series which had
         been registered under the Securities Act of 1933 other than pursuant
         to rule 24f-2 in a prior fiscal year, but which remained unsold at the
         beginning of the fiscal year:  None


8.       Number and amount of securities registered during the fiscal year
         other than pursuant to rule 24f-2:  None


9.       Number and aggregate sale price of securities sold during the fiscal
         year:

         337,096,270 shares with aggregate sales price of $337,096.270


10.      Number and aggregate sale price of securities sold during the fiscal
         year in reliance upon registration pursuant to rule 24f-2:

         337,096,270 shares with aggregate sale price of $337,096,270
<PAGE>   2
11.      Number and aggregate sale price of securities issued during the fiscal
         year in connection with dividend reinvestment plans, if applicable
         (see Instruction B.7):

         -0-


12.      Calculation of registration fee:


<TABLE>
         <S>     <C>                                                                                 <C>
         (i)     Aggregate sale price of securities sold during the fiscal year 
                 in reliance on rule 24f-2 (from Item 10):
                                                                                                     $337,096,270
                                                                                                      -----------

         (ii)    Aggregate price of shares issued in connection with dividend 
                 reinvestment plans (from Item 11):
                                                                                                     +    -0-    
                                                                                                      -----------

         (iii)   Aggregate price of shares redeemed or repurchased during the 
                 fiscal year (if applicable):

                                                                                                     -338,801,089
                                                                                                      -----------

         (iv)    Aggregate price of shares redeemed or repurchased and previously 
                 applied as a reduction to filing fees pursuant to
                 rule 24e-2 (if applicable):
                                                                                                     +    -0-    
                                                                                                      -----------

         (v)     Net aggregate price of securities sold and issued during the fiscal 
                 year in reliance on rule 24f-2 [line (i), plus
                 line (ii), less line (iii), plus line (iv)] (if applicable):
                                                                                                     ($1,704,819)
                                                                                                     ------------

         (vi)    Multiplier prescribed by Section 6(b) of the Securities Act of 1933 
                 or other applicable law or regulation (see Instruction C.6):
                                                                                                        x    .303
                                                                                                         --------

         (vii)   Fee due [line (i) or line (v) multiplied by line (vi)]:
                                                                                                     $    -0-    
                                                                                                      ===========
</TABLE>


13.      Check box if fees are being remitted to the Commission's lock box
         depository as described in section 3a of the Commission's Rules of
         Informal and Other Procedures (17 CFR 202.3a).    [  ]

         Date of mailing or wire transfer of filing fees to the Commission's
         lockbox depository:  _______________, 1997


                                   SIGNATURES

This report has been signed below by the following persons on behalf of the
issuer and in the capacities and on the dates indicated.


By (Signature and Title)                 /s/ William K. Piche         
                                  ------------------------------------
                                  William K. Piche, Executive Director

Date February 19, 1997


<PAGE>   1

                           DAVIS WRIGHT TREMAINE LLP
                              2600 Century Square
                               1501 Fourth Avenue
                         Seattle, Washington 98101-1688
                                 (206) 622-3150
                                 (206) 628-7699





                               February 19, 1997





California Hospital and Health Facilities Trust
7901 Stoneridge Drive, Suite 500
Pleasanton, California  94588

         Re:  Registration Statement on Form N-1A,
              File Nos. 811-6575; 33-46137

Ladies/Gentlemen:

         In connection with the referenced Registration Statement on Form N-1A,
as amended, filed by the Hospital and Health Facilities Trust (the "Trust")
with the Securities and Exchange Commission pursuant to the Securities Act of
1933, as amended (the "Act"), you have requested us to furnish our opinion as
to the legality of 337,096,270 shares of the California Hospital and Health
Facilities Liquid Asset Fund (the "Shares") which have been registered under
the Act.

         We have reviewed the Registration Statement, the Declaration of Trust
pursuant to which the Trust and the Fund were established and certain records
of the Trust's proceedings.  We have been furnished with and have examined
originals or copies, certified or otherwise identified to our satisfaction, of
such records of the Trust, agreements and other instruments, certificates of
officers and representatives of the Trust, certificates of public officials and
other documents as we have deemed necessary as a basis for the opinions
hereinafter expressed.

         Based on the foregoing, we are of the opinion that the Shares, when
issued, were legally issued, fully paid, and non-assessable.
<PAGE>   2
California Hospital and Health
  Facilities Trust
February 19, 1997
Page 2



         We hereby consent to the use of this opinion in connection with your
Form 24F-2, Annual Notice of Securities Sold, being filed with respect to your
fiscal year ended December 31, 1996.

                                                   Very truly yours,

                                                   DAVIS WRIGHT TREMAINE LLP


                                                   /s/ Davis Wright Tremaine LLP


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission